Inventor

Thomas Francois Durand-Reville

Inventor

Belmont, MA, US

Overview

5→

Patents

2016–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes23%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%

C07DHeterocyclic compounds23%

Y02ATechnologies for adaptation to climate change23%

C07BGeneral methods of organic chemistry5%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%

PatentTitleYear

10,800,778Beta-lactamase inhibitor compounds2020 10,376,499Combination therapy for treatment of resistant bacterial infections2019 9,968,593Combination therapy for treatment of resistant bacterial infections2018 9,623,014'Î²-lactamase inhibitor compounds'2017 9,309,245'Beta-lactamase inhibitor compounds'2016

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2016–2020Patents assigned to ENTASIS THERAPEUTICS LTD (5)· patent assignee history

2016–2018Based in Waltham, MA, US· patent location history

2017–2020Based in Belmont, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ENTASIS THERAPEUTICS LTD	5	2016–2020

Locations

Location	Patents	Span
Belmont, Massachusetts, US	3	2017–2020
Waltham, Massachusetts, US	2	2016–2018